Carol M. Dutkowski

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*

Richard A. McClelland, Denise Barrow, Tracie‐Ann Madden et al. · Endocrinology · 2001 · 249 citations · Full text

Breast Oncology, Ici 182,780, Cancer Biology +19

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)

Stephen Hiscox, L. Morgan, Denise Barrow et al. · Clinical & Experimental Metastasis · 2004 · 111 citations

Breast Oncology, Tamoxifen Resistance, Medicine +11

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

Nicola Jordan, Carol M. Dutkowski, Denise Barrow et al. · Breast Cancer Research · 2014 · 70 citations · Full text

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer

Andrew Stone, Fátima Valdés‐Mora, Julia M.W. Gee et al. · PLoS ONE · 2012 · 62 citations · Full text

Breast Oncology, Genetics, Epigenetics +18

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145

Helen Jones, Carol M. Dutkowski, Denise Barrow et al. · International Journal of Cancer · 1997 · 44 citations · Full text

Human Growth, Tumor Biology, Oncology +16